Qiong H. Xie

826 Zhangheng Road, Zhangjiang Hi Tech Park
Pudong, 201203, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 73 publications

Research progress of chimeric receptor cell therapy in autoimmune kidney diseases

Research progress of chimeric receptor cell therapy in autoimmune kidney diseases

Journal: Zhonghua nei ke za zhi

Published: March 16, 2026

DHODH is a synthetic lethal target in PIK3CA-mutant colorectal cancer.

DHODH is a synthetic lethal target in PIK3CA-mutant colorectal cancer.

Journal: Cell reports

Published: January 29, 2026

Correction to "Structure-Activity Relationship of N-Cyclopropylmethyl-7α-[para-(arylcarboxamido)phenyl]-6,14-endoethano-tetrahydronorthebaines as Potent and Selective Kappa Opioid Receptor Agonists".

Correction to "Structure-Activity Relationship of N-Cyclopropylmethyl-7α-[para-(arylcarboxamido)phenyl]-6,14-endoethano-tetrahydronorthebaines as Potent and Selective Kappa Opioid Receptor Agonists".

Journal: Journal of medicinal chemistry

Published: December 31, 2025

Structure-Activity Relationship of N-Cyclopropylmethyl-7α-[para-(arylcarboxamido)phenyl]-6,14-endoethano-tetrahydronorthebaines as Potent and Selective Kappa Opioid Receptor Agonists.

Structure-Activity Relationship of N-Cyclopropylmethyl-7α-[para-(arylcarboxamido)phenyl]-6,14-endoethano-tetrahydronorthebaines as Potent and Selective Kappa Opioid Receptor Agonists.

Journal: Journal of medicinal chemistry

Published: July 28, 2025

Design, synthesis, and biological activity of novel para-substituted phenylamino and phenyl derivatives of northebaine as selective delta opioid receptor agonists.

Design, synthesis, and biological activity of novel para-substituted phenylamino and phenyl derivatives of northebaine as selective delta opioid receptor agonists.

Journal: Bioorganic & medicinal chemistry

Published: July 04, 2025

Corrigendum to "Design, synthesis, and biological evaluation of novel BTK-targeting proteolysis targeting chimeras (PROTACs) with enhanced pharmacokinetic properties" [Eur. J. Med. Chem. 289 (2025) 117420].

Corrigendum to "Design, synthesis, and biological evaluation of novel BTK-targeting proteolysis targeting chimeras (PROTACs) with enhanced pharmacokinetic properties" [Eur. J. Med. Chem. 289 (2025) 117420].

Journal: European journal of medicinal chemistry

Published: May 25, 2025

Design, synthesis, and biological evaluation of novel BTK-targeting proteolysis targeting chimeras (PROTACs) with enhanced pharmacokinetic properties.

Design, synthesis, and biological evaluation of novel BTK-targeting proteolysis targeting chimeras (PROTACs) with enhanced pharmacokinetic properties.

Journal: European journal of medicinal chemistry

Published: January 06, 2025

Structure-activity relationship analysis of meta-substituted N-cyclopropylmethyl-nornepenthones with mixed KOR/MOR activities.

Structure-activity relationship analysis of meta-substituted N-cyclopropylmethyl-nornepenthones with mixed KOR/MOR activities.

Journal: European journal of medicinal chemistry

Published: December 19, 2024

Nanotechnology-Assisted mesenchymal stem cells treatment for improved cartilage regeneration: A review of current practices.

Nanotechnology-Assisted mesenchymal stem cells treatment for improved cartilage regeneration: A review of current practices.

Journal: Biochemical pharmacology

Published: November 18, 2024

Evaluation of XQ528 tartrate on embryo-fetus developmental toxicity in SD rats and genotoxicity.

Evaluation of XQ528 tartrate on embryo-fetus developmental toxicity in SD rats and genotoxicity.

Journal: Drug and chemical toxicology

Published: August 30, 2024

Current status of nano-embedded growth factors and stem cells delivery to bone for targeted repair and regeneration.

Current status of nano-embedded growth factors and stem cells delivery to bone for targeted repair and regeneration.

Journal: Journal of orthopaedic translation

Published: August 19, 2024

Discovery of an Ortho-Substituted N-Cyclopropylmethyl-7α-phenyl-6,14-endoethano-tetrahydronorthebaine Derivative as a Selective and Potent Kappa Opioid Receptor Agonist with Subsided Sedative Effect.

Discovery of an Ortho-Substituted N-Cyclopropylmethyl-7α-phenyl-6,14-endoethano-tetrahydronorthebaine Derivative as a Selective and Potent Kappa Opioid Receptor Agonist with Subsided Sedative Effect.

Journal: Journal of medicinal chemistry

Published: April 22, 2024

Showing 1-12 of 73

Last Updated: 09/26/2026